News
Global commission to pave the way for equal precision health
A new Lancet Commission on Precision Health has been launched to develop a comprehensive framework for integrating precision approaches into health systems worldwide. Researchers from Karolinska Institutet, Lund university and Genomic Medicine Sweden are contributing...
Sweden’s regions surpass 500,000 completed genomic analyses – national coordination drives precision diagnostics forward
More than half a million genomics-based analyses have now been performed in routine healthcare in Sweden. This milestone represents a major breakthrough for precision diagnostics and highlights the results of nearly a decade of national collaboration to make advanced...
Electronic Informed Consent to Facilitate Research on Rare Diseases
Research on rare diagnoses and the development of precision medicine depend on patients being able to share their health data in a secure and ethical manner.The research study in which a digital platform was developed to collect electronic informed consent shows that...
National initiative to deliver more precise drug treatment
The answer to why medicines work differently in different people is often found in our genes. Genomic Medicine Sweden is now taking a major step towards making pharmacogenetic testing available at all university hospitals. With a national gene panel, more patients...
Government Proposes New National Coordination Structure for Precision Health
The government has decided on a national coordination structure for precision health, with the goal that all patients will have equal access to the personalised care of the future. The assignment has been given to the National Board of Health and Welfare, which,...
Genomic Medicine Sweden launches new report on advances in precision medicine
Genomic Medicine Sweden (GMS) has published the report Collaboration in Precision Medicine since 2017, which summarises recent developments in precision medicine in Sweden. The report shows how national collaboration between healthcare, academia, government agencies,...
New clinical study will provide more cancer patients with targeted treatment
FOCU.SE is a new Swedish study in which genetic analysis of tumours is used to match cancer patients with targeted drugs outside of approved indication. The aim is to give more people access to effective treatment, while gathering valuable knowledge for the future. In...
Long-read genome sequencing: transforming genetic diagnostics for rare diseases
Despite rapid advances in genome and exome sequencing, many individuals with rare diseases remain undiagnosed. In a perspective article published in Nature Genetics, researchers highlight how long-read whole genome sequencing, LR-WGS, offers a paradigm shift in...